PAOG nascholing Jeugdgez Maastricht 25 Januar Tomris Cesuroglu

  • Slides: 21
Download presentation
PAOG nascholing Jeugdgez Maastricht, 25 Januar Tomris Cesuroglu, MD Institute for Public Health Genomics

PAOG nascholing Jeugdgez Maastricht, 25 Januar Tomris Cesuroglu, MD Institute for Public Health Genomics

Research into Child Health in Europe RICHE http: //childhealthresearch. eu

Research into Child Health in Europe RICHE http: //childhealthresearch. eu

RICHE An EU funded project (FP 7, Mar 2010 to Feb 2013) A project

RICHE An EU funded project (FP 7, Mar 2010 to Feb 2013) A project for child health researchers, practitioners, policy makers, and those who make decisions affecting children Defining the current pattern of child health research in Europe, seeing what's not being done, and identifying paths to the future of the research Future proofing child health research policy in Europe Meeting the future needs of European policy makers, funders, and children. http: //childhealthresearch. eu

Home Page http: //childhealthresearch. eu

Home Page http: //childhealthresearch. eu

An example http: //childhealthresearch. eu

An example http: //childhealthresearch. eu

What's to be done? Join us! Put up your Put up your own work

What's to be done? Join us! Put up your Put up your own work colleagues projects report funders http: //childhealthresearch. eu

Perspectives in Personalized Health Care Tomris Cesuroglu, MD Institute for Public Health Genomics PAOG

Perspectives in Personalized Health Care Tomris Cesuroglu, MD Institute for Public Health Genomics PAOG nascholing Jeugdgezondheidszorg Maastricht, 25 January 2011

1% of burden of disease 22% of burden of disease 77% of burden of

1% of burden of disease 22% of burden of disease 77% of burden of disease Disease ____________________ threshold Life style External factors Genetic structure Genetic diseases External factors *Slide used with the courtesy of GENAR Institute for Public Health and Genomics Research Complex diseases

An Example to a Single Nucleotide Polymorphism (SNP) Start Codon Stop Codon ┐└ TAT

An Example to a Single Nucleotide Polymorphism (SNP) Start Codon Stop Codon ┐└ TAT ATA TCG AGC TAC ATG GGC CCG TAC ATG ATA TAT CGT GCA ACC TGG GTA CAT AAT TTA TCG AGC ATT TAA CGA GCT TGA ACT ┐└

An Example to a Single Nucleotide Polymorphism (SNP) Start Codon Stop Codon ┐└ TAT

An Example to a Single Nucleotide Polymorphism (SNP) Start Codon Stop Codon ┐└ TAT ATA TCG AGC TAC ATG GGC CCG TAC ATG ATA TAT CGT GCA GCC CGG GTA CAT AAT TTA TCG AGC ATT TAA CGA GCT TGA ACT ┐└

Gene and Environment/Life Style Interaction Genetic Polymorphism Dark skin Fair skin Which one is

Gene and Environment/Life Style Interaction Genetic Polymorphism Dark skin Fair skin Which one is better? *Slide series used with the courtesy of GENAR Institute for Public Health and Genomics Research

Genetic variation: Is it good or bad? Fair skin Norway Nigeria Dark skin Happily

Genetic variation: Is it good or bad? Fair skin Norway Nigeria Dark skin Happily living in Fjords Happily living under African sun

Genetic variation: Is it good or bad? Fair skin Norway Nigeria Dark skin

Genetic variation: Is it good or bad? Fair skin Norway Nigeria Dark skin

Genetic variation: Is it good or bad? Fair skin Norway Nigeria • Gets red

Genetic variation: Is it good or bad? Fair skin Norway Nigeria • Gets red • Burns • Melanoma develops Dark skin

Genetic variation: Is it good or bad? Fair skin • Not enough sunshine •

Genetic variation: Is it good or bad? Fair skin • Not enough sunshine • Vitamin D deficiency • Develops osteoporosis Norway Nigeria Dark skin • Gets red • Burns • Melanoma develops

Genetic variation: Is it good or bad? Fair skin • Not enough sunshine •

Genetic variation: Is it good or bad? Fair skin • Not enough sunshine • Vitamin D deficiency • Develops osteoporosis Norway Nigeria Dark skin Positive intervention: Protecion from the sun

Genetic variation: Is it good or bad? Fair skin Positive intervention: Vitamin D supplements

Genetic variation: Is it good or bad? Fair skin Positive intervention: Vitamin D supplements Norway Nigeria Dark skin Positive intervention: Protecion from the sun

Eric Assamoa Transcription (m. RNA production) Translation in ribosom (synthesis of amino acid chain)

Eric Assamoa Transcription (m. RNA production) Translation in ribosom (synthesis of amino acid chain) Protein GSTP 1 Effective detoxification GSTP 1 (A 313 G Homozygous) Protein Ineffective detoxification

Disease Threshold Early Symptoms Threshold Check-Up Early Diagnosis and Treatment Death Conception Life Style

Disease Threshold Early Symptoms Threshold Check-Up Early Diagnosis and Treatment Death Conception Life Style and Environmental Conditions Genetic Predisposition Pathology Development Phase I *Slide used with the courtesy of GENAR Institute for Public Health and Genomics Research Early Disease Symp. Phase III Phase II

Thank you for your attention! Tomris Cesuroglu, MD t. cesuroglu@maastrichtuniversity. nl

Thank you for your attention! Tomris Cesuroglu, MD t. cesuroglu@maastrichtuniversity. nl